- Category
- Micro (2024-25)
- Udyam number
- UDYAM-HR-13-0015211

Bioxtreme Pharma Private Limited
About Bioxtreme Pharma Private Limited
Data last updated:
Bioxtreme Pharma Private Limited is a private limited company based in Panchkula, Haryana, India. It operates in the medical equipment retail and distribution segment of the healthcare sector. It was incorporated on 15 April 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Haryana, under CIN U24230HR2021PTC094502. Its GSTIN is 06AAJCB7989H1Z2 (Haryana).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Avadhesh Kumar Singh and Kali Charan Jaiswal.
Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at P.No – 315 1/A P – II Panchkula, Haryana, India – 134113.
As per the financials filed for FY 2025, the company reported a revenue of ₹2.62 Cr, a growth of 21% compared to the previous year. For the same year it recorded a net profit of ₹2.09 Lakh (net margin 0.8%) and EBITDA of ₹3.2 Lakh (EBITDA margin 1.2%).
Bioxtreme Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-HR-13-0015211).
Company details
Recognitions & Rankings of Bioxtreme Pharma
Contact details
Bioxtreme Pharma Private Limited's registered office is in Panchkula, Haryana. Its e-mail address is in the company report.
- Email
- Registered AddressP.No – 315 1/A P – II Panchkula, Haryana, India – 134113
- IndustryHealthcare, Medical Equipment Retail & Distribution
To see the full contact details of Bioxtreme Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Bioxtreme Pharma is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale and retail trade and repair of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 45 | Wholesale and retail trade and repair of motor vehicles and motorcycles |
To see the full business activity and turnover split of Bioxtreme Pharma Private Limited, buy the company report.
Financials of Bioxtreme Pharma Private Limited
FY 2025 filings availableBioxtreme Pharma Private Limited reported revenue of ₹2.62 Cr (up 21% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 21% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹3.2 Lakh | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹2.09 Lakh | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 1.2% | |||
| Net Profit Margin | 0.8% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Bioxtreme Pharma Private Limited, buy the company report.
Board of directors of Bioxtreme Pharma Private Limited
Bioxtreme Pharma has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Avadhesh Kumar Singh Also directs: Anshi Infratech Private Limited | Director | 15 Apr 2021 | 5 Years 6 Months | Current |
| Kali Charan Jaiswal | Director | 15 Apr 2021 | 5 Years 6 Months | Current |
Auditor
Bioxtreme Pharma Private Limited is audited by VIKAS SANJIV & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| VIKAS SANJIV & ASSOCIATES | FY 2023 | 018361N |
Shareholding
The shareholding of Bioxtreme Pharma Private Limited is on record for 2 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Bioxtreme Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Bioxtreme Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Bioxtreme Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Bioxtreme Pharma Private Limited has 1 active EPFO establishment as of Apr 03, 2024.
GST
Bioxtreme Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 06AAJCB7989H1Z2 | Haryana | Active | 24 May 2022 |
To see the full GST registrations and return filing status of Bioxtreme Pharma Private Limited, buy the company report.
Recent activity
Bioxtreme Pharma Private Limited has 2 board changes on record since 2021: 2 appointments. The latest: Avadhesh Kumar Singh was appointed as Director on 15 Apr 2021.
Frequently asked questions
Bioxtreme Pharma is an active private limited company based in Panchkula, Haryana, India. The company works in medical equipment retail and distribution, within the healthcare industry. It was incorporated on 15 April 2021 (5+ years old) and is registered under CIN U24230HR2021PTC094502.
Bioxtreme Pharma has 2 current directors:
- Avadhesh Kumar Singh - Director
- Kali Charan Jaiswal - Director
The latest financial statements of Bioxtreme Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 29 September 2025. Year-wise statements from FY 2022 are in the company report.
The GSTIN of Bioxtreme Pharma is 06AAJCB7989H1Z2, registered in Haryana.
The CIN (Corporate Identification Number) of Bioxtreme Pharma is U24230HR2021PTC094502. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Bioxtreme Pharma was incorporated on 15 April 2021, making it 5+ years old. It is registered with the Registrar of Companies, Haryana.
Avadhesh Kumar Singh was appointed as Director on 15 Apr 2021. Kali Charan Jaiswal was appointed as Director on 15 Apr 2021.
Yes, Bioxtreme Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-HR-13-0015211).
The registered office of Bioxtreme Pharma is at P.No – 315 1A P – II Panchkula, Haryana, India – 134113.
Bioxtreme Pharma operates in the healthcare industry, in the medical equipment retail and distribution segment.